Renoux A J, Sala-Hamrick K J, Carducci N M, Frazer M, Halsey K E, Sutton M A, Dolan D F, Murphy G G, Todd P K
Department of Neurology, USA; Department of Molecular and Integrative Physiology, USA.
Department of Neurology, USA.
Behav Brain Res. 2014 Jul 1;267:42-5. doi: 10.1016/j.bbr.2014.03.013. Epub 2014 Mar 19.
Fragile X syndrome (FXS) is a common inherited cause of intellectual disability that results from a CGG repeat expansion in the FMR1 gene. Large repeat expansions trigger both transcriptional and translational suppression of Fragile X protein (FMRP) production. Fragile X-associated Tremor/Ataxia Syndrome (FXTAS) is an allelic neurodegenerative disease caused by smaller "pre-mutation" CGG repeat expansions that enhance FMR1 transcription but lead to translational inefficiency and reduced FMRP expression in animal models. Sensorimotor gating as measured by pre-pulse inhibition (PPI) is altered in both FXS patients and Fmr1 knock out (KO) mice. Similarly, FXTAS patients have demonstrated PPI deficits. Recent work suggests there may be overlapping synaptic defects between Fmr1 KO and CGG knock-in premutation mouse models (CGG KI). We therefore sought to interrogate PPI in CGG KI mice. Using a quiet PPI protocol more akin to human testing conditions, we find that Fmr1 KO animals have significantly impaired PPI. Using this same protocol, we find CGG KI mice demonstrate an age-dependent impairment in PPI compared to wild type (WT) controls. This study describes a novel phenotype in CGG KI mice that can be used in future therapeutic development targeting premutation associated symptoms.
脆性X综合征(FXS)是一种常见的遗传性智力障碍病因,由FMR1基因中的CGG重复序列扩增所致。大量的重复序列扩增会引发脆性X蛋白(FMRP)产生的转录和翻译抑制。脆性X相关震颤/共济失调综合征(FXTAS)是一种等位基因神经退行性疾病,由较小的“前突变”CGG重复序列扩增引起,这种扩增会增强FMR1转录,但在动物模型中导致翻译效率低下和FMRP表达降低。通过前脉冲抑制(PPI)测量的感觉运动门控在FXS患者和Fmr1基因敲除(KO)小鼠中均发生改变。同样,FXTAS患者也表现出PPI缺陷。最近的研究表明,Fmr1基因敲除小鼠和CGG基因敲入前突变小鼠模型(CGG KI)之间可能存在重叠的突触缺陷。因此,我们试图研究CGG KI小鼠的PPI。使用一种更类似于人体测试条件的安静PPI方案,我们发现Fmr1基因敲除动物的PPI显著受损。使用相同的方案,我们发现与野生型(WT)对照相比,CGG KI小鼠在PPI方面表现出年龄依赖性损伤。这项研究描述了CGG KI小鼠中的一种新表型,可用于未来针对前突变相关症状的治疗开发。